Proposals on the Board composition and remuneration by

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Proposals on the Board composition and remuneration by Shareholders’ Nomination Board of Sponda

Sponda Plc          Stock Exchange Release 22 January 2015, 10:40  

Proposals on the Board composition and remuneration by Shareholders’ Nomination Board of Sponda

In its meeting, the Shareholders’ Nomination Board of Sponda has decided to propose to the Annual General Meeting to be held 16 March 2015 that the Board will consist of seven members. The Nomination Board further propose that Kaj-Gustaf Bergh, Christian Elfving, Paul Hartwall, Juha Laaksonen, Leena Laitinen, Arja Talma and Raimo Valo to be re-elected for the Board of Directors.

The Nomination Board proposes to the Annual General Meeting that the annual remuneration payable to the members of the Board to be elected at the Annual General Meeting for the term until the close of the Annual General Meeting in 2016: EUR 66,000 for the Chairman, EUR 40,000 for the Vice Chairman, and EUR 33,000 for each member. Additional compensation of EUR 1,000 shall be paid for the Chairman of the Board for the Board meetings attended and EUR 600 shall be paid for the members of the Board for the Board meetings attended. The Nomination Board proposes that EUR 600 shall be paid for member of the Board for committee meetings and EUR 1,000 shall be paid for the Chairman of the Audit Committee for the Audit Committee meetings attended. The Nomination Board proposes that 40 % of the fixed annual remuneration be paid in Sponda shares purchased from the market. The shares will be purchased within two weeks from the release of the interim report January 1 – March 31, 2015 of Sponda Plc. The Nomination Board proposes that travel costs be reimbursed in accordance with the principles approved by the Finnish Tax Administration.

The Board of Directors will incorporate the proposals into the Annual General meeting notice which will be published later.

The Shareholders’ Nomination Board consisted of three largest shareholders on 30 September 2014:

Oy Palsk Ab, Kaj-Gustaf Bergh; Mutual Pension Fund Varma, Pekka Pajamo; and HC Fastigheter Holding Oy Ab, Ole Johansson.

For further information, please contact: Kaj-Gustaf Bergh, Chairman of the Shareholders’ Nomination Board, Tel. +358 40 524 7730.

Sponda Plc

Kari Inkinen President and CEO

Sponda Plc is a property investment company specializing in commercial properties in the largest cities in Finland. Sponda's business concept is to own, lease and develop retail and office properties and shopping centres into environments that promote the business success of its clients. The fair value of Sponda's investment properties is approximately EUR 3.1 billion and the leasable area is around 1.2 million m².

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Capacitor Bank Market Growth Predictions Through 2033

Updated Category News Views 216

Capacitor Bank Market Set for Substantial Growth Recently, a comprehensive report highlighted the significant potential of the global capacitor bank market, forecasting a growth trajectory that sees its value increasing from $4.3 billion in 2023 to an impressive $6.8 billion by 2033. This translates to a compound annual growth rate (CAGR) of 4.8% during the period from...

Continue Reading
Understanding Rental Affordability Trends Across Major Markets

Updated Category News Views 291

Rental Affordability Trends in August 2024 As summer draws to a close, many renters are taking a close look at the housing market to gauge current affordability rates. A recent report highlights encouraging data, showing that rental affordability has generally improved in various major U.S. regions. This article outlines the key takeaways regarding rental affordability...

Continue Reading
Stallergenes Greer’s Palforzia® Gains European Approval for Toddlers

Updated Category News Views 134

Palforzia® Receives European Commission Approval for Toddlers Stallergenes Greer, a leader in allergen immunotherapy, has exciting news: the European Commission has officially approved the use of Palforzia® for toddlers aged 1 to 3 years with confirmed peanut allergies. This significant step enhances the treatment landscape for peanut allergies and opens new doors for...

Continue Reading
ProVen Growth and Income VCT's Latest Interim Management Insights

Updated Category News Views 174

ProVen Growth and Income VCT plc Overview ProVen Growth and Income VCT plc, known for its investment strategies and market presence, has released its Interim Management Statement for the recent quarter. This report highlights significant financial data and key developments that occurred from March to May 2025, offering shareholders insights into the company’s...

Continue Reading
Treefera Recognized as 2025 Gartner® Cool Vendor in Tech

Updated Category News Views 179

Treefera Honored as a 2025 Gartner® Cool Vendor Treefera has recently celebrated a significant milestone by being named a 2025 Gartner® Cool Vendor in Sourcing and Procurement Technology. This prestigious acknowledgment underscores Treefera's innovative contributions to the supply chain sector, particularly in providing first-mile visibility which is crucial for...

Continue Reading